These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28634883)

  • 1. A Minimal Continuous-Time Markov Pharmacometric Model.
    Schindler E; Karlsson MO
    AAPS J; 2017 Sep; 19(5):1424-1435. PubMed ID: 28634883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Longitudinal-Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models.
    Lu T; Yang Y; Jin JY; Kågedal M
    CPT Pharmacometrics Syst Pharmacol; 2020 Feb; 9(2):96-105. PubMed ID: 31877239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Likert pain score modeling: a Markov integer model and an autoregressive continuous model.
    Plan EL; Elshoff JP; Stockis A; Sargentini-Maier ML; Karlsson MO
    Clin Pharmacol Ther; 2012 May; 91(5):820-8. PubMed ID: 22433987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handling underlying discrete variables with bivariate mixed hidden Markov models in NONMEM.
    Brekkan A; Jönsson S; Karlsson MO; Plan EL
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):591-604. PubMed ID: 31654267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling a spontaneously reported side effect by use of a Markov mixed-effects model.
    Zingmark PH; Kågedal M; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):261-81. PubMed ID: 16283538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of type I error rates when modeling ordered categorical data in NONMEM.
    Wählby U; Matolcsi K; Karlsson MO; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2004 Feb; 31(1):61-74. PubMed ID: 15346852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic model of lithium and drug compliance assessment.
    Pérez-Castelló I; Mangas-Sanjuan V; González-García I; Gonzalez-Alvarez I; Bermejo M; Marco-Garbayo JL; Trocóniz IF
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1868-1876. PubMed ID: 27865605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-Markov Arnason-Schwarz models.
    King R; Langrock R
    Biometrics; 2016 Jun; 72(2):619-28. PubMed ID: 26584064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scalable approach for continuous time Markov models with covariates.
    Hatami F; Ocampo A; Graham G; Nichols TE; Ganjgahi H
    Biostatistics; 2024 Jul; 25(3):681-701. PubMed ID: 37433567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid landmark Aalen-Johansen estimator for transition probabilities in partially non-Markov multi-state models.
    Maltzahn N; Hoff R; Aalen OO; Mehlum IS; Putter H; Gran JM
    Lifetime Data Anal; 2021 Oct; 27(4):737-760. PubMed ID: 34595580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ORDMKV: a computer program fitting proportional odds model for multi-state Markov process.
    Guo W; Marshall G
    Comput Methods Programs Biomed; 1995 Apr; 46(3):257-63. PubMed ID: 7656559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A continuous time version and a generalization of a Markov-recapture model for trapping experiments.
    Alpizar-Jara R; Smith CE
    Math Biosci; 2008; 214(1-2):11-9. PubMed ID: 18556026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxing the assumption of constant transition rates in a multi-state model in hospital epidemiology.
    Hill M; Lambert PC; Crowther MJ
    BMC Med Res Methodol; 2021 Jan; 21(1):16. PubMed ID: 33430778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inference for transition probabilities in non-Markov multi-state models.
    Andersen PK; Wandall ENS; Pohar Perme M
    Lifetime Data Anal; 2022 Oct; 28(4):585-604. PubMed ID: 35764854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent mixed Markov modelling of smoking transitions using Monte Carlo bootstrapping.
    Mannan HR; Koval JJ
    Stat Methods Med Res; 2003 Mar; 12(2):125-46. PubMed ID: 12665207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regularized continuous-time Markov Model via elastic net.
    Huang S; Hu C; Bell ML; Billheimer D; Guerra S; Roe D; Vasquez MM; Bedrick EJ
    Biometrics; 2018 Sep; 74(3):1045-1054. PubMed ID: 29534304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation.
    van Rosmalen J; Toy M; O'Mahony JF
    Med Decis Making; 2013 Aug; 33(6):767-79. PubMed ID: 23715464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A piecewise-homogeneous Markov chain process of lung transplantation.
    Sharples LD; Taylor GI; Faddy M
    J Epidemiol Biostat; 2001; 6(4):349-55. PubMed ID: 12036269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. tdc.msm: an R library for the analysis of multi-state survival data.
    Meira-Machado L; Cadarso-Suárez C; de Uña-Alvarez J
    Comput Methods Programs Biomed; 2007 May; 86(2):131-40. PubMed ID: 17350136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian method for construction of Markov models to describe dynamics on various time-scales.
    Rains EK; Andersen HC
    J Chem Phys; 2010 Oct; 133(14):144113. PubMed ID: 20949993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.